Skip to main content

A Statement from the Leadership of the Institute of Human Virology on the Passing of Stewart Greenebaum

December 12, 2017

Stewart Greenebaum

An Outstanding Businessman, A Generous Philanthropist, A Dedicated Humanitarian, and A Great Friend

Baltimore, MD, December 12, 2017: The Institute of Human Virology (IHV) at the University of Maryland School of Medicine mourns the passing of Stewart Greenebaum, a lifelong Baltimore resident, former president of Greenebaum and Rose Associates, and past chairman of the IHV Board of Advisors, as well as a guiding force in the establishment of the IHV at the University of Maryland, Baltimore.

"These days are the saddest in the history of the Institute of Human Virology,” said Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Director, Institute of Human Virology, University of Maryland School of Medicine.  “We have lost a great man, a great friend - a friend to us personally and a friend to the Institute.  Stewart Greenebaum was a husband, father, grandfather, and a successful businessman with an immense heart for those in need, and for those trying to help what he called the human condition.  Stewart was, through and through, a great Baltimorean in his fierce dedication to improve the City.  He will be forever marked in our collective memories."

Mr. Greenebaum was a major force in recruiting the IHV’s three co-founders, Robert Gallo, MD, Robert Redfield, MD, The Robert C. Gallo, MD, Endowed Professorship in Translational Medicine, Associate Director, Director, Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, and William Blattner, MD, now retired, to form the IHV in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System.  Mr. Greenebaum subsequently served as Board Chairman of the IHV in its early, formative years and helped build the foundation from which the IHV could and would flourish. He received the Institute’s inaugural Lifetime Achievement Award for Public Service in 2004.

“Stewart helped us in so many ways with his wise counsel and his generous philanthropic contributions,” said Dr. Gallo.  “We will miss his storytelling and we will miss his jokes, which were fantastic, unending, and always appropriate for the current point in a conversation.  We truly enjoyed our dinners with him.  Further, my wife and I personally were particularly thrilled to have Stewart and his wife, Marlene, with us on some of our most memorable trips including to Spain and Israel.”

Dr. Gallo continued, “We also greatly appreciate the Greenebaums for originating and sponsoring the IHV’s Annual Marlene and Stewart Greenebaum Lecture Series, which has evolved into one of the most prestigious lectures at the University of Maryland, Baltimore. At this sad time, my colleagues and I send his family our most sincere, heartfelt condolences. Stewart’s legacy will continue to live in the hearts he touched, many of which were here at the IHV.”

About the Institute of Human Virology

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland, and the University of Maryland Medical System, the IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology, and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably, HIV the virus that causes AIDS. For more information, visit and follow us on Twitter @IHVmaryland.

L to R: William Blattner, MD, Myron M. Levine, MD, DTPH, Stewart Greenebaum, Sir Gustav Nossal, AC, CBE, FRS, Robert Gallo, MD, and Robert Redfield, MD at the Annual Greenebaum Lecture series in 2007 when Sir Gustav Nossal, Professor Emeritus, The University of Melbourne (Australia) and Former Director, The Walter and Eliza Hall Institute of Medical Research, presented “The Twenty First Century: A Turning Point in Global Health Reform.”  Since 2004, Marlene and Stewart Greenebaum have sponsored an annual lecture series hosted by the IHV. Speakers include persons who have made substantial scientific contributions and focus on bettering the human condition. Each year, IHV’s faculty invite leaders in the field of human disease to present this prestigious lecture before IHV and campus leaders, students, faculty and staff.


Institute of Human Virology
Nora Samaranayake
Director of Marketing and Public Relations
(410) 706-8614 (phone)
(410) 706-1952 (fax)

Related stories

    Wednesday, September 19, 2018

    Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine will lead a $12 million dollar project to improve the morbidity and mortality of people with opioid use disorder (OUD). Utilizing a novel compound, IHV researches will implement a series of investigations, entitled SEARCH, to evaluate the underlying mechanisms of craving reduction as a strategy to prevent opioid misuse, dependence, and relapse. The grant is awarded through the National Institutes of Health’s (NIH) Helping to End Addiction Long-term (HEAL) Initiative, made possible through groundbreaking funding from the U.S. Congress.

    Wednesday, November 29, 2017

    To Mark World AIDS Day, Institute of Human Virology Releases Video on Dr. Robert Gallo

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) released a video on Dr. Robert Gallo, a trailblazer in HIV research, in advance of World AIDS Day, December 1. While many know Dr. Gallo for his pioneering work in AIDS research, the short video focuses on Dr. Gallo’s life and legacy in its entirety, including his pioneering discovery of human retroviruses.

    Tuesday, October 25, 2016

    "A Call to End HIV/AIDS in America" IHV Director Dr. Robert Gallo's Op-Ed in the Huffington Post

    As the new Administration is presented with great challenges facing the United States, one will be a longtime foe, the U.S. HIV/AIDS epidemic. Since President Barack Obama was elected in 2008, I have publicly called on our country’s leaders to utilize the largest global health initiative in history - the President’s Emergency Plan for AIDS Relief (PEPFAR) - as a model to address the U.S. epidemic.

    Monday, August 22, 2016

    Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research

    The Institute of Human Virology (IHV) announced a $14.4M grant from NIAID to advance HIV vaccine research to solve a major challenge: produce long-lasting antibodies to protect against HIV infection.

    Thursday, March 10, 2016

    UM SOM Establishes Two Endowed Professorships Through Private Gifts and Matching State Funds

    University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the School has been awarded matching funds from the Maryland Department of Business and Economic Development (DBED) as part of the Maryland E-Nnovation Initiative Fund program. The funds, when combined with private philanthropy, will enable UM SOM to establish two new endowed professorships – one in human virology and vaccine development, the other in surgical science and entrepreneurship.

    Tuesday, September 29, 2015

    Institute of Human Virology Hosts International Meeting of Prominent AIDS Researchers

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine is hosting IHV’s 17th Annual International Meeting Sunday, September 27 through Wednesday, September 30 at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland.